(C9)-CP 47,497

(C9)-CP 47,497 Structure

(C9)-CP 47,497 is a synthetic cannabinoid that is structurally related to CP 47,497. It is a potent agonist of the cannabinoid receptors, specifically the CB1 receptor and CB2 receptor. This compound is part of a class of synthetic cannabinoids that have been used in scientific research to understand the endocannabinoid system and its role in various physiological processes.

Chemical Structure and Properties

(C9)-CP 47,497 is a derivative of CP 47,497, where the pentyl side chain is replaced with a nonyl side chain. This modification results in a compound with increased potency and affinity for cannabinoid receptors. The chemical structure of (C9)-CP 47,497 includes a cyclohexylphenol core, which is a common feature among synthetic cannabinoids.

Pharmacology

(C9)-CP 47,497 acts as a full agonist at both the CB1 and CB2 receptors. These receptors are part of the G protein-coupled receptor family and are primarily involved in the modulation of neurotransmitter release in the central nervous system and immune system responses. The activation of these receptors by (C9)-CP 47,497 can lead to various physiological effects, including analgesia, anti-inflammatory effects, and alterations in mood and perception.

Legal Status

The legal status of (C9)-CP 47,497 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in the broader category of synthetic cannabinoids, which are frequently subject to regulatory control.

Research Applications

(C9)-CP 47,497 is used in scientific research to study the endocannabinoid system and its role in health and disease. It serves as a tool to investigate the pharmacological properties of cannabinoid receptors and to develop potential therapeutic agents targeting these receptors. Research involving (C9)-CP 47,497 has contributed to the understanding of cannabinoid receptor signaling pathways and their implications in conditions such as chronic pain, neurodegenerative diseases, and immune disorders.

Safety and Toxicity

The safety profile of (C9)-CP 47,497 is not well-established, and its use outside of a research setting is not recommended. Synthetic cannabinoids, including (C9)-CP 47,497, have been associated with adverse effects such as tachycardia, hypertension, anxiety, and psychosis. Long-term use may lead to dependence and withdrawal symptoms.

See Also

• CP 47,497
• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system

References

‎